Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2008
03/18/2008US7344711 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs
03/18/2008US7344703 Mycobacterial sulfation pathway proteins and methods of use thereof
03/18/2008CA2448908C Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization
03/18/2008CA2425634C Method and device for creating micro-arrays
03/18/2008CA2400735C Process for producing peptides by using in vitro transcription/translation system
03/18/2008CA2383554C Methods for the detection, analysis and isolation of nascent proteins
03/18/2008CA2337495C Melanocortin-4 receptor gene and use as a genetic marker for fat content, weight gain, and/or feed consumption of animals
03/18/2008CA2328955C Fetal testing for prediction of low birth weight
03/18/2008CA2320430C Recombinant mistletoe lectins
03/18/2008CA2255774C Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
03/18/2008CA2243829C Method and device for the simultaneous isolation of genomic dna and high-purity total rna
03/18/2008CA2185043C Monoclonal antibodies recognizing tie-receptor and their use
03/18/2008CA2181073C Tissue-specific enhancer active in prostate
03/18/2008CA2175490C Methods of analysis and manipulation of dna utilizing mismatch repair systems
03/18/2008CA2166102C Redirection of cellular immunity by receptor chimeras
03/18/2008CA2089735C Ryegrass pollen allergen
03/18/2008CA2015060C Novel antibody delivery system for biological response modifiers
03/14/2008CA2568354A1 Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
03/13/2008WO2008031098A1 Binary amino acid libraries for fibronectin type iii polypeptide monobodies
03/13/2008WO2008031009A2 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
03/13/2008WO2008030996A2 Sirna and methods of manufacture
03/13/2008WO2008030614A2 Suppressor trna transcription in vertebrate cells
03/13/2008WO2008030613A2 Hybrid suppressor trna for vertebrate cells
03/13/2008WO2008030564A2 Aglycosylated antibodies and methods of making and using those antibodies
03/13/2008WO2008030423A2 A liquid-based method for producing plant embryos
03/13/2008WO2008030283A1 Methods of diagnosing and treating complications of pregnancy
03/13/2008WO2008030251A1 Deglycosylated anti-amyloid beta antibodies
03/13/2008WO2008030239A1 RNA INTERFERENCE MEDIATED INHIBITION OF HISTONE DEACETYLASE (HDAC) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
03/13/2008WO2008030122A1 Biomarkers
03/13/2008WO2008029942A1 Use of activated cytokinin-biosynthesizing enzyme gene
03/13/2008WO2008029921A1 Function-modified phenylalanine dehydrogenase, and method for analysis of amino acid in biological sample using the enzyme
03/13/2008WO2008029920A1 Method for analysis of l-methionine in biological sample using function-modified phenylalanine dehydrogenase
03/13/2008WO2008029838A1 Method for study, determination or evaluation by gene expression analysis
03/13/2008WO2008029807A1 Novel polypeptide having cytotoxicity against cancer, method for screening for the polypeptide, and use of the polypeptide
03/13/2008WO2008029790A1 Novel nucleic acid
03/13/2008WO2008029789A1 Method of determining size of fatty acid content in intramuscular fat of cattle based on genotype of fatty acid synthase and method of determining eating quality of beef based on the result
03/13/2008WO2008029667A1 Method of detecting binding site to dna-binding protein in dna
03/13/2008WO2008029646A1 Screening method for therapeutic agent for amyotrophic lateral sclerosis
03/13/2008WO2008029619A1 Ena antisense oligonucleotide having sequence-specific action
03/13/2008WO2008029414A2 Use of transcription factor inhibitor in the manufacture of a medicament
03/13/2008WO2008029276A2 Compositions and methods for the treatment of ophthalmic disease
03/13/2008WO2008029189A1 Regulation of expression of p140cap protein in tumors
03/13/2008WO2008029085A2 Polymerase
03/13/2008WO2008028889A1 Synthetic gene
03/13/2008WO2008028661A2 Potexvirus- derived replicon
03/13/2008WO2008028601A2 Method for improving the specific effector function of single-chain antigen-recognizing genetic constructs (scarc) through murinization thereof
03/13/2008WO2008028535A1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production
03/13/2008WO2008028534A1 Aptamers labelled with gallium-68
03/13/2008WO2008028405A1 Neukinase, a downstream protein of neuregulin
03/13/2008WO2008028257A1 Diagnostics and therapeutics of neurological disease
03/13/2008WO2008028250A1 Therapeutic agents, targets and diagnostics
03/13/2008WO2008013664A3 Methods of producing pancreatic hormones
03/13/2008WO2008002472A3 Systematic evaluation of sequence and activity relationships using site evaluation libraries for engineering multiple properties
03/13/2008WO2007149406A9 Modified coagulation factor ix polypeptides and use thereof for treatment
03/13/2008WO2007144342A3 Use of a plastid-lipid associated protein promoter (pap promoter) for heterologous gene expression
03/13/2008WO2007143442A3 A novel virulence determinant within the e2 structural glycoprotein of classical swine fever virus
03/13/2008WO2007138324A3 Materials and complexes for the delivery of biologically-active material to cells
03/13/2008WO2007136758A3 Sirna inhibition of p13k p85, p110, and akt2 and methods of use
03/13/2008WO2007130697A3 Anti-ephb4 antibodies and methods using same
03/13/2008WO2007129114A3 Aptamers directed to recombinant muc1
03/13/2008WO2007128553A9 Mig12
03/13/2008WO2007127476A3 Monoclonal antibodies specific for pancreatic endocrine, exocrine or ductal cell
03/13/2008WO2007125371A3 Process for making oligopeptides
03/13/2008WO2007124312A3 Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use
03/13/2008WO2007119165A3 A method for detecting intracytoplasmic protein/protein interactions
03/13/2008WO2007112753A3 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
03/13/2008WO2007112299A3 Enzymatic preparation of (s) amino acid from (r,s) amino acid or from keto acid
03/13/2008WO2007110695A3 Modular genomes for synthetic biology and metabolic engineering
03/13/2008WO2007109441A3 Polypeptides having endoglucanase activity and polynucleotides encoding same
03/13/2008WO2007109174A3 Compositions and methods for modulation of mcl-1 expression
03/13/2008WO2007103307A3 Site-specific incorporation of amino acids into molecules
03/13/2008WO2007103225A3 Engineered listeria and methods of use thereof
03/13/2008WO2007096899A3 Affinity polypeptide for purification of recombinant proteins
03/13/2008WO2007092314A3 Esterases and related nucleic acids and methods
03/13/2008WO2007087153A3 Cyst nematode resistant transgenic plants
03/13/2008WO2007084708A3 Tat-028 and methods of assessing and treating cancer
03/13/2008WO2007067818A8 Plasmids and packaging cell lines for use in phage display
03/13/2008WO2007048644A3 Prevention of retroviral infectivity through interference with ppt
03/13/2008WO2007048628A3 Structures of active guide rna molecules and method of selection
03/13/2008WO2007016566A9 Production of reprogrammed cells with restored potential
03/13/2008US20080066206 Expression vector comprising nucleotide sequences which express cleavable short interfering nucleic acid for use as tool in controlling gene expression in plants
03/13/2008US20080066204 Nucleotide sequences coding isomerase for use as tool in enhancing starch biosynthesis in plants
03/13/2008US20080066203 Genes For Microsomal Delta-12 Fatty Acid Desaturases And Hydroxylases From Plants
03/13/2008US20080066202 Using vector transformation to generate disease, insect and herbicide resistant plants
03/13/2008US20080066200 Transgenic plant which serves as bioreactor for expression of humanized glycoproteins with reduced fucose and xylose residues
03/13/2008US20080066199 Using expressed sequence tags as gene targeting tool in transformation and generation of transgenic crop plants
03/13/2008US20080066198 Modulation of Flowering Time and Growth Cessation in Perennial Plants
03/13/2008US20080066197 Pluripotent cells from rat and other species
03/13/2008US20080066196 Inhibitory polynucleotides used to downregulate expression of genes of interest in transgenic cells
03/13/2008US20080066195 Taste Receptors of the T1r Family Form Domestic Cat
03/13/2008US20080064866 Plasmid for efficient transformation and generation of disease, insect and herbicide resistant plants
03/13/2008US20080064865 Short interfering RNA sequences for use as therapeutic tools in treatment of cancer, diabetes and nervous system disorders
03/13/2008US20080064864 Expression vector comprising nucleotide sequences coding carbohydrate modifiying enzyme for use in enhancing quality of foodstuffs and baked goods
03/13/2008US20080064863 DNA containing poly(ethylene oxide)-modified oligo- or poly-nucleotide; gene therapy
03/13/2008US20080064859 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells
03/13/2008US20080064764 Isolated nucleic acids; antibody for selective binding; biodrug treating osteoporosis, osteoblast, bone disorders, osteocalcin mediated disorder
03/13/2008US20080064735 Method for controlling harmful organisms in crops of useful plants
03/13/2008US20080064651 A 21-base antisense oligonucleotide which inhibits gene expression of testosterone-repressed prostate message-2 by tumor cells; prostate and renal cell cancer; enhanced chemosensitivity, hormone and radiation sensitivities
03/13/2008US20080064648 Methods and Compositions Relating to Lipid Accumulation
03/13/2008US20080064647 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active
1 ... 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 ... 4023